top of page
header_news.png
  • Foto van schrijver: Saffelberg Investments
    Saffelberg Investments
  • 7 apr 2020
  • 1 minuten om te lezen

Bijgewerkt op: 9 apr 2020

Liège, 30 March 2012 - Uteron Pharma successfully completed a 14 million EUR capital increase. This new equity round enables Uteron Pharma to further finance its strong growth ambitions as a specialist in female healthcare.


 
 
 

Comments


© 2020 created by Saffelberg Investments. All rights reserved.

bottom of page